Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 4
1995 4
1996 3
1997 2
1998 2
1999 7
2000 2
2001 6
2002 3
2003 7
2004 6
2005 6
2006 5
2007 10
2008 8
2009 9
2010 7
2011 6
2012 5
2013 8
2014 4
2015 4
2016 5
2017 3
2018 5
2019 11
2020 11
2021 14
2022 15
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Results by year

Filters applied: . Clear all
Page 1
Asplenia and spleen hypofunction.
Lenti MV, Luu S, Carsetti R, Osier F, Ogwang R, Nnodu OE, Wiedermann U, Spencer J, Locatelli F, Corazza GR, Di Sabatino A. Lenti MV, et al. Among authors: wiedermann u. Nat Rev Dis Primers. 2022 Nov 3;8(1):71. doi: 10.1038/s41572-022-00399-x. Nat Rev Dis Primers. 2022. PMID: 36329079 Review.
Antworten auf brennende Fragen an klinische Allergolog*innen im Zusammenhang mit den neuen COVID-19-Impfstoffen.
Altrichter S, Wöhrl S, Horak F, Idzko M, Jordakieva G, Untersmayr E, Szepfalusi Z, Zieglmayer P, Jensen-Jarolim E, Wiedermann U, Rosenkranz A, Hötzenecker W. Altrichter S, et al. Among authors: wiedermann u. Allergo J. 2021;30(5):48-54. doi: 10.1007/s15007-021-4847-0. Epub 2021 Aug 13. Allergo J. 2021. PMID: 34393385 Free PMC article. Review. German.
Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe : Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA).
Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Novak N, Merk HF, Rabe U, Schlenter WW, Ring J, Wehrmann W, Mülleneisen NK, Wrede H, Fuchs T, Jensen-Jarolim E. Untersmayr E, et al. Among authors: wiedermann u. Allergo J. 2021;30(5):34-47. doi: 10.1007/s15007-021-4848-z. Epub 2021 Aug 13. Allergo J. 2021. PMID: 34393384 Free PMC article. Review. German. No abstract available.
Editorial: Challenges in Vaccinology.
Lavelle EC, Carsetti R, Pickl WF, Wiedermann U. Lavelle EC, et al. Among authors: wiedermann u. Front Immunol. 2020 Dec 17;11:632537. doi: 10.3389/fimmu.2020.632537. eCollection 2020. Front Immunol. 2020. PMID: 33391292 Free PMC article. No abstract available.
Traveler's Diarrhea.
Kollaritsch H, Paulke-Korinek M, Wiedermann U. Kollaritsch H, et al. Among authors: wiedermann u. Infect Dis Clin North Am. 2012 Sep;26(3):691-706. doi: 10.1016/j.idc.2012.06.002. Infect Dis Clin North Am. 2012. PMID: 22963778 Review.
Emerging targets for anticancer vaccination: PD-1.
Tobias J, Steinberger P, Drinić M, Wiedermann U. Tobias J, et al. Among authors: wiedermann u. ESMO Open. 2021 Oct;6(5):100278. doi: 10.1016/j.esmoop.2021.100278. Epub 2021 Oct 11. ESMO Open. 2021. PMID: 34649221 Free PMC article. Review.
Murine models for mucosal tolerance in allergy.
Smole U, Schabussova I, Pickl WF, Wiedermann U. Smole U, et al. Among authors: wiedermann u. Semin Immunol. 2017 Apr;30:12-27. doi: 10.1016/j.smim.2017.07.007. Epub 2017 Aug 12. Semin Immunol. 2017. PMID: 28807539 Free PMC article. Review.
Vaccination against Her-2/neu, with focus on peptide-based vaccines.
Tobias J, Garner-Spitzer E, Drinić M, Wiedermann U. Tobias J, et al. Among authors: wiedermann u. ESMO Open. 2022 Feb;7(1):100361. doi: 10.1016/j.esmoop.2021.100361. Epub 2022 Jan 10. ESMO Open. 2022. PMID: 35026721 Free PMC article. Review.
A Biomimetic, Silaffin R5-Based Antigen Delivery Platform.
Reichinger D, Reithofer M, Hohagen M, Drinic M, Tobias J, Wiedermann U, Kleitz F, Jahn-Schmid B, Becker CFW. Reichinger D, et al. Among authors: wiedermann u. Pharmaceutics. 2022 Dec 29;15(1):121. doi: 10.3390/pharmaceutics15010121. Pharmaceutics. 2022. PMID: 36678751 Free PMC article.
181 results